15th Annual Symposium pushes boundaries

Posted on Sep 30, 2008

PIH's 15th annual Thomas J. White Symposium focused on the theme "Pushing boundaries: past, present, and future." The program featured a panel of HIV patients who shared their stories of being provided with life-saving antiretroviral drugs. Another panel featured activists who have used the PIH model and philosophy of social justice to create their own programs to provide healthcare to the poor and inspire the next generation of social justice activists. View these panels as well as speeches from PIH co-founders Paul Farmer and Ophelia Dahl.

Studies confirm XDR-TB can be cured

Posted on Aug 1, 2008

Extensively drug-resistant tuberculosis (XDR-TB) is curable with intensive and specialized care conclude two recent studies published in the New England Journal of Medicine (NEJM) and The Lancet. Researchers found that fully 60 percent of the patients enrolled in the studies with XDR-TB were successfully treated and cured.

Socios En Salud steps up training and advocacy in the fight against MDR-TB

Posted on Mar 31, 2007

Socios En Salud, long recognized as a leader for innovating community-based treatment for MDR-TB and for training other health professionals how to do it, has redoubled training activities, sending teams to Haiti and Africa and hosting nurses from Latin America.

PIH looks back on 2006

Posted on Jan 15, 2007

For PIH and our partner organizations, 2006 was a year of daunting challenges and striking achievements. For the second consecutive year, we launched a new project, this time in Lesotho. We also strengthened and expanded our operations in countries where we have been working for many years. We constructed and inaugurated new facilities in Peru, Haiti and Rwanda. We substantially increased the numbers of patients we serve and initiated major new programs to serve them better.

Socios En Salud update, January 2007

Posted on Jan 8, 2007

Improving and expanding DOTS-Plus: Throughout 2006, SES worked with the Peruvian Ministry of Health and with local health officials to expand treatment for MDR-TB patients both within and beyond Lima.